Skip to main content

Table 3 Clinical, Hormonal and Echocardiographic variables (mean ± SD) in patients with Thyroid Dysfunction before and after treatment

From: Myocardial ultrasonic tissue characterization in patients with thyroid dysfunction

  Hyperthyroidism
(n = 10)
Hypothyroidism
(n = 6)
Subclinical Hypothyroidism
(n = 8)
  Baseline Treatment Baseline Treatment Baseline Treatment
HR (min-1) 90.7 ± 23.5 80 ± 16.4 67.3 ± 11.1 69.7 ± 13.8 78.8 ± 14.3 78.3 ± 10.7
EF (%) 70.4 ± 5.6 71.7 ± 5.1 70.7 ± 4.7 71.0 ± 5.2 71.2 ± 5.4 72 ± 4.4
LVMI (g/m2) 72.2 ± 11.1 68.0 ± 11.5 82.0 ± 15.7 80.7 ± 16.0 70.8 ± 9.7 69.2 ± 10.2
LVd (cm) 4.9 ± 0.3 4.7 ± 0.3 a 4.9 ± 0.2 4.9 ± 0.2 4.8 ± 0.3 4.8 ± 0.3
TSH (mU/L) 0.009 ± 0.01 2.1 ± 1.4 b 141.2 ± 96.9 1.7 ± 1.5 a 10.6 ± 7.1 2.4 ± 1.3a
FT4 (ng/dl) 4.3 ± 1.6 1.2 ± 0.2 b 0.2 ± 0.08 1.53 ± 0.2a 1.0 ± 0.2 1.4 ± 0.3 a
FT3 (pg/ml) 13.5 ± 9.2 3.1 ± 0.9 - - - -
  1. a = p < 0.05; b = p < 0.005 vs baseline
  2. HR = heart rate; EF = ejection fraction; LVMI = left ventricular mass index; LVd = left ventricular diastolic dimension; TSH = thyroid stimulator hormone; FT4 = free T4; FT3 = free T3